Skip to Main Content

Paper Details

Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.
Cell Death Dis
1
2022
AT, AT/, AT/RT, AT/RT cell line models, Atypical teratoid/rhabdoid tumor, DR5, Drosophila, MYC, RT, RTs, SHH, SMARCA4, SMARCB1, SMARCB1 deficiency, STAT1, TYR, atypical teratoid/rhabdoid tumors, brain tumor, cilia-associated genes, infants, mouse, patient, primary
Author NameAffiliation
Lena Bl??melHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Lena Bl??mel
Lena Bl??melInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Nan QinHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Nan Qin
Nan QinInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
David PauckHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
David Pauck
David PauckInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Daniel PicardHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Daniel Picard
Daniel PicardInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Kai St??hlerBiological and Medical Research Center (BMFZ), Heinrich Heine University Dusseldorf
Kai St??hlerInstitute of Molecular Medicine, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Frauke-Dorothee MeyerHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Frauke-Dorothee Meyer
Frauke-Dorothee MeyerInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Sarah G??bbelsHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Sarah G??bbels
Sarah G??bbelsInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Serap ErkekHopp Childrens Cancer Center (KiTZ)
Serap ErkekGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolHopp Childrens Cancer Center (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolHopp Childrens Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Stefan M PfisterHopp Childrens Cancer Center (KiTZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Childrens Cancer Center (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHeidelberg University Hospital
Pascal D JohannHopp Childrens Cancer Center (KiTZ)
Pascal D JohannSwabian Childrens' Cancer Center, University Medical Center
Pascal D JohannHeidelberg University Hospital
Pascal D JohannGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Michael C FrühwaldSwabian Childrens' Cancer Center, University Medical Center
Arndt BorkhardtHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Arndt Borkhardt
Arndt BorkhardtHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Arndt Borkhardt
Guido Reifenberger
Guido ReifenbergerInstitute of Neuropathology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Claudia C FariaInstituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa
Claudia C FariaHospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Ute FischerHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
Ute Fischer
Jasmin BartlHematology and Clinical Immunology, Heinrich Heine University Dusseldorf, and University Hospital Dusseldorf
  • 1 - 50

Datasets

Release 1.2